| Trouble viewing this mail? View online version | |||||||||||
|
|||||||||||
October 01, 2026 Dear Reader, Vaccine hesitancy is not a single diagnosis but a crowded waiting room of safety concerns, distrust, lived experience, political identity, misinformation, and legitimate questions. Our feature article looks beyond the unhelpful “pro-” versus “anti-vaccine” binary to examine how confidence is lost—and rebuilt.The central lesson is simple: facts matter, but facts alone do not vaccinate. Evidence is interpreted through trust in clinicians, institutions, and communities. Effective communication must therefore be scientifically rigorous, honest about uncertainty, and responsive to people’s real concerns. A graph can be excellent; it simply cannot make someone feel heard. In our infodemic age, when misinformation travels at fiber-optic speed while trust arrives on foot, listening may be one of public health’s most important interventions.
The TBEV has been detected in various regions of the UK, according to an article reviewed by
Dr. Bröker reviews,
raising questions about the true incidence of the disease on the island.
Singapore is positioning outbreak preparedness as both a national responsibility and a global public good. In a timely
UN address,
Health Minister Ong Ye Kung outlines three complementary plans: stronger global rules, resilient regional manufacturing, and connected surveillance and response networks—backed by Singapore’s investment in vaccine platforms, partnerships, and regulatory readiness.
Global outbreak activity
remains substantial. Ebola transmission continues in the Democratic Republic of Congo, while mpox and cholera persist across multiple regions. Measles cases remain elevated in the Americas, including the United States. European authorities are monitoring seasonal mosquito-borne threats, and multiple foodborne outbreaks remain under investigation in the United States.
Lastly, our
literature review
spans the forces shaping health today: deep regional inequities, persistent pandemic-preparedness gaps, promising but early GBS vaccine data, renewed reassurance on maternal Tdap safety, and the challenge of vaccine misinformation. Returning to our feature this week, we ask which communication strategies genuinely create engagement—not merely clicks.
Enjoy the reading! Stay tuned, stay healthy, and get the vaccines you deserve! Warm regards, Editor-in-Chief, Global Health Press |
|||||||||||
| Highlights of the week | |||||||||||
|
|||||||||||
|
|||||||||||
Be part of the Global Health Press Community - id-ea.org |
|||||||||||
|
|||||||||||
| You are receiving this newsletter because you registered at id-ea.org. At Global Health Press Pte Ltd, we are committed to safeguarding your privacy. Your contact details are never shared with third parties. If you no longer wish to receive updates from us, you can unsubscribe here. Copyright © 2009-2026 Global Health Press Pte Ltd. Reg. No. 200921795N |
|||||||||||